Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 1 3Phase 2 2Phase 4 1Phase 2/3 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 1NETWORK 1INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 502Breast 19Thoracic 11Gastrointestinal 11Gynecologic 8Plasma cell 4CNS 4Sarcoma 3Other 3Head & Neck 3Classical hematology 3Other neoplasm 2Lymphoid 2Other solid neoplasm 1Other hematologic neoplasm 1Myeloid 1Endocrine 1Dermatologic 1

Conditions

Anemia 64Neoplasms 38Venous Thromboembolism 29Leukemia 21Anemia, Refractory, with Excess of Blasts 20Myelodysplastic Syndromes 19Lymphoma 14Thrombocytopenia 13Multiple Myeloma 12Leukemia, Myelomonocytic, Chronic 12Venous Thrombosis 11Pulmonary Embolism 11Febrile Neutropenia 11Breast Neoplasms 10Myeloproliferative Disorders 9Lymphoma, Non-Hodgkin 9Leukemia, Lymphocytic, Chronic, B-Cell 9Neoplasms, Plasma Cell 8Lymphoma, Follicular 8Leukemia, Myeloid, Acute 8Primary Myelofibrosis 6Neutropenia 6Hodgkin Disease 6Hemophilia A 6Lung Neoplasms 5Anemia, Refractory 5Waldenstrom Macroglobulinemia 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Precancerous Conditions 4Lymphoproliferative Disorders 4

Interventions

Epoetin Alfa 2Goserelin 1Estradiol 1Dexamethasone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Prostatic Neoplasms × Classical hematology × Clear all
NCT00060398 2023-06-15

Epoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer

Eastern Cooperative Oncology Group

Phase 3 Completed
282 enrolled
Classical hematologyGenitourinary

Anemia, Fatigue, Prostatic Neoplasms

NCT00303784 2020-11-27

PATCH

University College, London

Phase 3 Unknown
2,200 enrolled
Classical hematologyGenitourinary

Anemia, Osteoporosis, Prostatic Neoplasms, Hot Flashes

NCT00270166 2011-05-18

The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving Chemotherapy

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Phase 3 Completed
201 enrolled
BreastClassical hematologyGastrointestinalGenitourinaryGynecologicLymphoidPlasma cellThoracic

Anemia, Breast Neoplasms, Esophageal Neoplasms, Lymphoma, Multiple Myeloma, Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡